Companies: 48,687 Total Market Cap: 125800178376592.40

Roche Holding AG

SWX-ROG

Healthcare Drug Manufacturers - General

Rank #40

Market Cap 262.45 B

Volume 483,058.75

Price 329.53

Change (%) 0.78%

Country or region

Switzerland

Roche Holding AG's latest marketcap:

262.45 B

As of May 2, 2025, Roche Holding AG's market capitalization has reached $262.45 B. According to our data, Roche Holding AG is the 40th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	262.45 B
Revenue (ttm)	75.76 B
Net Income (ttm)	10.05 B
Shares Out	795.40 M
EPS (ttm)	12.52
Forward PE	13.31
Ex-Dividend Date	March 27, 2025
Earnings Date	April 25, 2025

Market Cap Chart

Data Updated: May 2, 2025

Roche Holding AG's yearly market capitalization.

Roche Holding AG has seen its market value drop from ₣264.24 B to ₣216.15 B since 2020, representing a total decrease of 18.20% and an annual compound decline rate (CAGR) of 4.53%.

Date	Market Cap	Change (%)
April 30, 2025	₣216.15 B	5.34%
December 30, 2024	₣205.19 B	4.12%
December 29, 2023	₣197.07 B	-23.96%
December 30, 2022	₣259.17 B	-15.53%
December 30, 2021	₣306.81 B	16.11%
December 30, 2020	₣264.24 B

Company Profile

About Roche Holding AG

Roche Holding AG is a global leader in pharmaceuticals and diagnostics, operating across Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Pharmaceutical Solutions

The company specializes in therapeutic areas including:

Anaemia and blood disorders
Solid and hematologic tumors
Dermatology and inflammatory diseases
Haemophilia and autoimmune conditions
Neurological and ophthalmological disorders
Respiratory diseases and transplantation

Diagnostics & Digital Health

Roche provides advanced diagnostic solutions, such as:

In vitro tests for cancer, diabetes, and infectious diseases (including Covid-19 and hepatitis)
Cutting-edge diagnostic instruments
Innovative digital health technologies

Founded in 1896, Roche is headquartered in Basel, Switzerland, and continues to drive advancements in healthcare worldwide.

Frequently Asked Questions

As of May 2, 2025, Roche Holding AG (including the parent company, if applicable) has an estimated market capitalization of $262.45 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Roche Holding AG global market capitalization ranking is approximately 40 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Switzerland
Founded	1896
IPO Date	n/a
Employees	103,249
CEO	Thomas Schinecker
Sector	Healthcare
Industry	Drug Manufacturers - General
Address	Grenzacherstrasse 124 Basel, 4070 Switzerland